Intellia Therapeutics, Inc.

LSE:0JBU Stock Report

Market Cap: US$1.5b

Intellia Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0JBU Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
02 Oct 24SellUS$38,248Michael DubeIndividual2,012US$19.01
01 Jul 24SellUS$9,287Eliana ClarkIndividual405US$22.93
04 Mar 24SellUS$19,959Eliana ClarkIndividual605US$32.99
04 Mar 24SellUS$75,778James BastaIndividual2,297US$32.99
03 Jan 24SellUS$114,216Derek HicksIndividual3,877US$29.46
03 Jan 24SellUS$158,053Glenn GoddardIndividual5,365US$29.46
03 Jan 24SellUS$162,973Laura Sepp-LorenzinoIndividual5,532US$29.46
03 Jan 24SellUS$172,135David LebwohlIndividual5,843US$29.46
03 Jan 24SellUS$566,310John LeonardIndividual19,223US$29.46
03 Jan 24SellUS$112,095James BastaIndividual3,805US$29.46
03 Jan 24SellUS$135,954Eliana ClarkIndividual4,608US$30.12

Insider Trading Volume

Insider Buying: 0JBU insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0JBU?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,281,6441.26%
General Public5,645,1985.54%
Institutions94,921,73093.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.7%.

Top Shareholders

Top 25 shareholders own 73.75% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12%
ARK Investment Management LLC
12,255,440US$186.4m5.69%1.32%
9.6%
BlackRock, Inc.
9,772,742US$148.6m1.82%no data
9.45%
The Vanguard Group, Inc.
9,627,804US$146.4m5.8%no data
6.18%
Nikko Asset Management Co., Ltd.
6,297,796US$95.8m93.3%0.03%
5.05%
State Street Global Advisors, Inc.
5,143,534US$78.2m17.9%no data
4.86%
Deep Track Capital, LP
4,950,000US$75.3m3.13%2.13%
2.69%
Federated Hermes, Inc.
2,740,765US$41.7m19.1%0.09%
2.3%
Geode Capital Management, LLC
2,343,310US$35.6m2.15%no data
2.3%
FMR LLC
2,337,596US$35.6m4.93%no data
2.15%
AllianceBernstein L.P.
2,193,787US$33.4m23.1%0.01%
2.01%
Contrarius Investment Management Ltd.
2,047,218US$31.1m6.88%1.54%
1.96%
Casdin Capital, LLC
2,000,000US$30.4m0%1.79%
1.56%
Morgan Stanley, Investment Banking and Brokerage Investments
1,593,744US$24.2m-0.13%no data
1.42%
Dimensional Fund Advisors LP
1,447,250US$22.0m9.26%no data
1.37%
Pictet Asset Management Limited
1,394,911US$21.2m87.5%0.02%
1.06%
Himension Capital (Singapore) Pte Ltd
1,075,711US$16.4m4.44%1.11%
1.01%
Two Sigma Advisers, LP
1,027,617US$15.6m33.5%0.03%
0.97%
Citadel Advisors LLC
989,439US$15.0m29.7%0.01%
0.96%
Two Sigma Investments, LP
980,380US$14.9m18.2%0.03%
0.85%
Northern Trust Global Investments
866,290US$13.2m3.7%no data
0.82%
John Leonard
830,546US$12.6m0%no data
0.81%
Charles Schwab Investment Management, Inc.
827,545US$12.6m4.77%no data
0.8%
Chevy Chase Trust Company
811,033US$12.3m-22.2%0.03%
0.79%
Morgan Stanley Investment Management Inc.
809,480US$12.3m43.4%0.01%
0.74%
Balyasny Asset Management L.P.
749,861US$11.4m116%0.03%